GCKR |
Q14397
|
glucokinase regulator
|
|
8.5E-19 |
0.604 |
0.615 |
79
|
13 |
SH2B3 |
Q9UQQ2
|
SH2B adaptor protein 3
|
|
1.0E-04 |
0.527 |
0.692 |
74
|
8 |
FADS2 |
O95864
|
fatty acid desaturase 2
|
|
1.00 |
0.575 |
0.692 |
74
|
50 |
CDKN2B-AS1 |
|
CDKN2B antisense RNA 1
|
|
|
0.491 |
0.769 |
69
|
53 |
FTO |
Q9C0B1
|
FTO alpha-ketoglutarate dependent dioxygenase
|
|
8.4E-08 |
0.486 |
0.885 |
64
|
61 |
FADS1 |
O60427
|
fatty acid desaturase 1
|
|
0.37 |
0.582 |
0.769 |
53
|
30 |
CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
52
|
70 |
TCF7L2 |
Q9NQB0
|
transcription factor 7 like 2
|
|
1.00 |
0.485 |
0.846 |
50
|
31 |
TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
44
|
49 |
IRF1-AS1 |
Q8N8D9
|
IRF1 antisense RNA 1
|
|
4.2E-03 |
0.670 |
0.385 |
41
|
26 |
MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
38
|
56 |
ZPR1 |
O75312
|
ZPR1 zinc finger
|
|
8.9E-09 |
0.674 |
0.462 |
36
|
16 |
CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
35
|
41 |
ZFHX3 |
Q15911 Q6ZP98
|
zinc finger homeobox 3
|
|
0.45 |
0.621 |
0.654 |
32
|
34 |
HECTD4 |
Q9Y4D8
|
HECT domain E3 ubiquitin protein ligase 4
|
|
1.00 |
0.700 |
0.462 |
31
|
11 |
MECOM |
Q03112
|
MDS1 and EVI1 complex locus
|
|
1.00 |
0.513 |
0.731 |
30
|
48 |
HFE |
Q30201
|
homeostatic iron regulator
|
|
2.6E-08 |
0.436 |
0.846 |
30
|
9 |
GBAP1 |
|
glucosylceramidase beta pseudogene 1
|
|
|
0.623 |
0.538 |
29
|
8 |
ASTN2 |
O75129
|
astrotactin 2
|
|
1.00 |
0.666 |
0.462 |
26
|
32 |
EBF1 |
Q9UH73
|
EBF transcription factor 1
|
|
1.00 |
0.584 |
0.654 |
24
|
42 |
SOX6 |
P35712
|
SRY-box transcription factor 6
|
|
1.00 |
0.578 |
0.615 |
24
|
41 |
TNXB |
P22105
|
tenascin XB
|
|
1.9E-02 |
0.572 |
0.731 |
24
|
26 |
BAZ1B |
Q9UIG0
|
bromodomain adjacent to zinc finger domain 1B
|
|
1.00 |
0.530 |
0.731 |
24
|
12 |
COL4A2 |
P08572
|
collagen type IV alpha 2 chain
|
|
3.6E-15 |
0.563 |
0.654 |
23
|
22 |